Canine influenza virus monoclonal antibody hybridoma cell line f112 and its application
A technology of hybridoma cell lines and monoclonal antibodies, which is applied in the direction of antibodies, antiviral agents, antiviral immunoglobulins, etc., can solve the problems that the application value has not been studied, and achieve good production and application prospects and strong antiviral activity Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0026] (1) Establishment of canine influenza virus monoclonal antibody hybridoma F112 strain
[0027] 1. Preparation of Canine Influenza Virus Immune Antigen
[0028] A / Canine / Nanjing / 11 / 2012(H3N2) (Wang Xiaoli, et al. Isolation and evolution analysis of a H3N2 subtype canine influenza virus. Chinese Journal of Animal Infectious Diseases, 2015,23(2):25-31) inoculated in 9-11 day-old SPF chicken embryos (purchased from Nanjing Tianbang Biotechnology Co., Ltd.), collected after 2-3 days with a hemagglutination titer greater than 2 6chicken embryo allantoic fluid. After the allantoic fluid was centrifuged at 5000r / min for 30min, the supernatant was taken, and then centrifuged at 8000r / min for 30min, and the supernatant was taken. After preliminary removal of impurities, ultracentrifuge at 30,000r / min for 3 hours, discard the supernatant, suspend the precipitate with an appropriate amount of PBS, prepare sucrose solutions of different concentrations, and use a pipette from high ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com